πŸ‡ΊπŸ‡Έ FDA
Patent

US 7358273

Inhibitors of caspases

granted A61KA61K38/00A61P

Quick answer

US patent 7358273 (Inhibitors of caspases) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00, A61P, A61P1/00, A61P1/04